| P50 | author | Valérie Boige | Q41786186 |
| | Marc Ychou | Q57036797 |
| P2093 | author name string | M Giovannini | |
| | E François | |
| | M Ducreux | |
| | T Conroy | |
| | D Peiffert | |
| | J F Seitz | |
| | Y Yataghene | |
| | F Viret | |
| | J P Metges | |
| P2860 | cites work | Global cancer statistics, 2002 | Q27860562 |
| | 5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus | Q33492832 |
| | Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer | Q33913953 |
| | A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomas | Q35993743 |
| | First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study | Q36610452 |
| | High-dose folinic acid with 5-fluorouracil bolus and continuous infusion in the treatment of advanced gastric and oesophageal adenocarcinoma | Q42390593 |
| | Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer | Q44028630 |
| | Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid | Q45019544 |
| | Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma | Q46454923 |
| | Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus | Q46513089 |
| | EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. | Q48111201 |
| | Concurrent oxaliplatin, 5-fluorouracil, and radiotherapy in the treatment of locally advanced esophageal carcinoma. | Q53571587 |
| | Survival of cancer patients in France: A population-based study from The Association of the French Cancer Registries (FRANCIM) | Q57566970 |
| | High-dose folinic acid, 5-fluorouracil bolus and continuous infusion in poor-prognosis patients with advanced measurable gastric cancer | Q70175918 |
| | Combined intensive chemoradiotherapy for organ preservation in patients with resectable and non-resectable oesophageal cancer | Q71550103 |
| | Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma | Q71760913 |
| | Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer | Q73707393 |
| | Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group | Q77424043 |
| | INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy | Q77706014 |
| | Management and prognosis of esophageal cancers: has progress been made? | Q81595553 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oxaliplatin | Q422327 |
| | phase I clinical trial | Q5452194 |
| | fluorouracil | Q238512 |
| P304 | page(s) | 1395-1401 | |
| P577 | publication date | 2008-10-07 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer | |
| P478 | volume | 99 | |